- 自己免疫疾患
- サイバー攻撃
- ドイツ
- ノネット
- 令和
- 技術
- 採用
- 科学
- 記者
- 防御
「自己免疫」の写真・グラフィックス・映像
- 提供元
- 日付
- 種類
- 向き
- カテゴリ
- 色
- 同義語オン
- 提供元
- 日付
- 24時間以内 0
- 48時間以内 0
- 72時間以内 0
- 7日以内 0
- 30日以内 2
- 1年以内 53
- 期間を指定 185
- 日付指定なし 185
- 種類
- 写真 176
- グラフィックス 8
- 映像 1
- 向き
- 縦 59
- 横 118
- 正方形 0
- カテゴリ
- ニュース
- スポーツ
- エンターテインメント
- 教育向け
- カテゴリ指定なし
- 色
- カラー 181
- モノクロ 4
- 同義語辞書
- 古い順
- 1
- 2
- 古い順
1998年04月21日Peter FondaUS actor Peter Fonda, recorded on April 21, 1998 in the SFB talk show “Alex“ in Berlin. The former “Easy Rider“ star is currently in Germany to present his latest film “Ulee‘s Gold.“ After many years in the acting offside, the now-59-year-old Hollywood actor gave the role of self-immolating beekeeper Ulee a Golden Globe and an Oscar nomination. | usage worldwide、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019081902052
00:43.442012年07月11日市原悦子さんが死去 生前の市原さんテレビドラマ「家政婦は見た！」シリーズなどで知られ、舞台や映画でも活躍した女優の市原悦子（本名塩見悦子）さんが１２日午後１時３１分、心不全のため東京都内の病院で死去した。８２歳。千葉市出身。 俳優座養成所を経て、１９５７年俳優座入団。 ７１年に俳優座を退団し、商業演劇や映画に進出。昼のドラマで脚光を浴びた後、２時間ドラマの顔として欠かせない存在に。エリート家庭の秘密をのぞき見する「家政婦は見た！」シリーズでは、庶民的な〝おばちゃん〞をコミカルに演じ、お茶の間から圧倒的な支持を受けた。 テレビアニメ「まんが日本昔ばなし」のナレーションや、朗読劇での明るくほのぼのとした語りも人気だった。 ２０１２年、大腸に腫瘍が見つかり、映画を降板。１６年に体調不良で入院し、自己免疫性脊髄炎と診断されていた。＜映像内容＞２０１２年７月１１日、橋田文化財団（橋田寿賀子理事長）の特別賞を受賞した時の市原さんの映像など。撮影は東京都内。※無音です。＝資料映像＝撮影日：２０１２（平成２４）年７月１１日、撮影場所：東京都内
商品コード: 2019011515882
2018年08月08日免疫性膵炎の原因物質特定自己免疫性膵炎発症実験のイメージ
商品コード: 2018080801023
2018年08月08日免疫性膵炎の原因物質特定自己免疫性膵炎発症実験のイメージ
商品コード: 2018080801022
2018年08月08日免疫性膵炎の原因物質特定自己免疫性膵炎発症実験のイメージ
商品コード: 2018080801025
2018年08月08日免疫性膵炎の原因物質特定自己免疫性膵炎発症実験のイメージ
商品コード: 2018080801024
2019年05月16日肝臓の難病、患者増える自己免疫性肝疾患の種類と推定患者数
商品コード: 2019051601539
2019年05月16日肝臓の難病、患者増える自己免疫性肝疾患の種類と推定患者数
商品コード: 2019051601547
2019年05月16日研究班のホームページ 肝臓の難病、患者増える自己免疫性肝疾患に関する情報を集めた、厚労省研究班作成のホームページ
商品コード: 2019051602289
2019年09月11日Pharmaceutical companies invest in Dessau11 September 2019, Saxony-Anhalt, Dessau-Roﾟlau: An employee of Oncotec Pharma Production is working on a new line for filling sterile cancer drugs. The manufacturer of essential cancer and autoimmune drugs currently employs around 300 people at the Dessau-Roﾟlau BioPharmaPark and has now invested 35 million euros in new facilities. Photo: Hendrik Schmidt/dpa-Zentralbild/ZB、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019091203963
2019年09月11日Pharmaceutical companies invest in Dessau11 September 2019, Saxony-Anhalt, Dessau-Roﾟlau: Small bottles with a sterile cancer drug run in the Oncotec Pharma production via a new plant. The manufacturer of essential cancer and autoimmune drugs currently employs around 300 people at the Dessau-Roﾟlau BioPharmaPark and has now invested 35 million euros in new facilities. Photo: Hendrik Schmidt/dpa-Zentralbild/ZB、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019091204417
2019年09月11日Pharmaceutical companies invest in Dessau11 September 2019, Saxony-Anhalt, Dessau-Roßlau: Maren Michel, Managing Director of Oncotec Pharma Produktion, and Jörg Hans, Managing Director of the parent company Medac, stand side by side at the Dessau site. Oncotec, manufacturer of essential cancer and autoimmune drugs, currently employs around 300 people at the BioPharmaPark Dessau-Roßlau site and has now invested 35 million euros in new facilities. Photo: Hendrik Schmidt/dpa-Zentralbild/ZB、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019091204474
2019年09月11日Pharmaceutical companies invest in Dessau11 September 2019, Saxony-Anhalt, Dessau-Roﾟlau: An employee of Oncotec Pharma Production is working on a new line for filling sterile cancer drugs. The manufacturer of essential cancer and autoimmune drugs currently employs around 300 people at the Dessau-Roﾟlau BioPharmaPark and has now invested 35 million euros in new facilities. Photo: Hendrik Schmidt/dpa-Zentralbild/ZB、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019091204427
2019年09月11日Pharmaceutical companies invest in Dessau11 September 2019, Saxony-Anhalt, Dessau-Roﾟlau: An employee of Oncotec Pharma Production is working on a new line for filling sterile cancer drugs. The manufacturer of essential cancer and autoimmune drugs currently employs around 300 people at the Dessau-Roﾟlau BioPharmaPark and has now invested 35 million euros in new facilities. Photo: Hendrik Schmidt/dpa-Zentralbild/ZB、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019091204429
2020年04月27日Prevention of type 1 diabetes27 April 2020, Saxony, Dresden: Five-month-old Ylvie from Oderwitz is held in her arms by her mother during a press appointment. The girl is the 100th participant in the study centre of the Europe-wide cooperation for the prevention of type 1 diabetes, GPPAD (“Global Platform for the Prevention of Autoimmune Diabetes“) at the Carl Gustav Carus University Hospital of the TU Dresden. Through genetic testing after birth within the so-called Freder1k study, children up to the age of four months with an increased risk of developing type 1 diabetes are discovered and can then participate in the POInT study. Photo: Robert Michael/dpa-Zentralbild/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2020042905351
2020年04月27日Prevention of type 1 diabetes27 April 2020, Saxony, Dresden: Five-month-old Ylvie from Oderwitz is held in her arms by her mother during a press appointment. The girl is the 100th participant in the study centre of the Europe-wide cooperation for the prevention of type 1 diabetes, GPPAD (“Global Platform for the Prevention of Autoimmune Diabetes“) at the Carl Gustav Carus University Hospital of the TU Dresden. Through genetic testing after birth within the so-called Freder1k study, children up to the age of four months with an increased risk of developing type 1 diabetes are discovered and can then participate in the POInT study. Photo: Robert Michael/dpa-Zentralbild/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2020042905135
2020年04月27日Prevention of type 1 diabetes27 April 2020, Saxony, Dresden: Five-month-old Ylvie from Oderwitz is held in her arms by her mother during a press appointment. The girl is the 100th participant in the study centre of the Europe-wide cooperation for the prevention of type 1 diabetes, GPPAD (“Global Platform for the Prevention of Autoimmune Diabetes“) at the Carl Gustav Carus University Hospital of the TU Dresden. Through genetic testing after birth within the so-called Freder1k study, children up to the age of four months with an increased risk of developing type 1 diabetes are discovered and can then participate in the POInT study. Photo: Robert Michael/dpa-Zentralbild/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2020042905157
2020年04月27日Prevention of type 1 diabetes27 April 2020, Saxony, Dresden: Five-month-old Ylvie from Oderwitz is held in her arms by her mother during a press appointment. The girl is the 100th participant in the study centre of the Europe-wide cooperation for the prevention of type 1 diabetes, GPPAD (“Global Platform for the Prevention of Autoimmune Diabetes“) at the Carl Gustav Carus University Hospital of the TU Dresden. Through genetic testing after birth within the so-called Freder1k study, children up to the age of four months with an increased risk of developing type 1 diabetes are discovered and can then participate in the POInT study. Photo: Robert Michael/dpa-Zentralbild/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2020042905368
2020年06月24日Russia Putin State Awards24.06.2020 Russian President Vladimir Putin and Biocad CEO Dmitry Morozov, developer of oncology and autoimmune medications, shake hands during a ceremony at the Moscow Kremlin to hand out national awards in the fields of science and technology, literature and art, humanitarian efforts, charity and human rights advocacy for the previous year, in Moscow, Russia. Mikhail Klimentyev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2020062706446
- 本画像はログイン後にご覧いただけます2020年10月28日南京紫金山実験室、高性能サーバーを発表江蘇省
１０月２８日、サイバースペース内在性セキュリティーデザインが施されたルーター。中国江蘇省南京市のネットワーク通信・セキュリティー紫金山実験室はこのほど、高性能サーバー「蓮花哪吒」を発表した。サイバースペース内在性セキュリティーデザインを新たに採用し、サーバーの持つ「自己免疫力」により、サイバー攻撃を防御する。（南京＝新華社記者／邱氷清）＝２０２０（令和２）年１０月２８日、クレジット：新華社／共同通信イメージズ
商品コード: 2020110201924
- 本画像はログイン後にご覧いただけます2020年10月28日南京紫金山実験室、高性能サーバーを発表江蘇省
１０月２８日、サイバースペース内在性セキュリティーデザインが施されたゲートウェイ。中国江蘇省南京市のネットワーク通信・セキュリティー紫金山実験室はこのほど、高性能サーバー「蓮花哪吒」を発表した。サイバースペース内在性セキュリティーデザインを新たに採用し、サーバーの持つ「自己免疫力」により、サイバー攻撃を防御する。（南京＝新華社記者／邱氷清）＝２０２０（令和２）年１０月２８日、クレジット：新華社／共同通信イメージズ
商品コード: 2020110201844
- 本画像はログイン後にご覧いただけます2020年10月28日南京紫金山実験室、高性能サーバーを発表江蘇省
１０月２８日、基本コンポーネント。中国江蘇省南京市のネットワーク通信・セキュリティー紫金山実験室はこのほど、高性能サーバー「蓮花哪吒」を発表した。サイバースペース内在性セキュリティーデザインを新たに採用し、サーバーの持つ「自己免疫力」により、サイバー攻撃を防御する。（南京＝新華社記者／邱氷清）＝２０２０（令和２）年１０月２８日、クレジット：新華社／共同通信イメージズ
商品コード: 2020110201852
- 本画像はログイン後にご覧いただけます2020年10月28日南京紫金山実験室、高性能サーバーを発表江蘇省
１０月２８日、高性能サーバー「蓮花哪吒」。中国江蘇省南京市のネットワーク通信・セキュリティー紫金山実験室はこのほど、高性能サーバー「蓮花哪吒」を発表した。サイバースペース内在性セキュリティーデザインを新たに採用し、サーバーの持つ「自己免疫力」により、サイバー攻撃を防御する。（南京＝新華社記者／邱氷清）＝２０２０（令和２）年１０月２８日、クレジット：新華社／共同通信イメージズ
商品コード: 2020110201930
2021年07月10日MedicationJuly 9, 2021, Memphis, Tennessee, USA: A nurse on disability prepares to take a handful of pills on July 10, 2021in Memphis, Tennessee. The pills have become part of her regiment since she developed medical problems and had to stop working. (Credit Image: © Karen Focht/ZUMA Wire)、クレジット：©Ｋａｒｅｎ Ｆｏｃｈｔ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021071208729
2021年07月10日MedicationJuly 9, 2021, Memphis, Tennessee, USA: A nurse on disability prepares to take a handful of pills on July 10, 2021in Memphis, Tennessee. The pills have become part of her regiment since she developed medical problems and had to stop working. (Credit Image: © Karen Focht/ZUMA Wire)、クレジット：©Ｋａｒｅｎ Ｆｏｃｈｔ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021071208618
2021年07月10日MedicationJuly 9, 2021, Memphis, Tennessee, USA: A nurse on disability prepares to take a handful of pills on July 10, 2021in Memphis, Tennessee. The pills have become part of her regiment since she developed medical problems and had to stop working. (Credit Image: © Karen Focht/ZUMA Wire)、クレジット：©Ｋａｒｅｎ Ｆｏｃｈｔ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021071208332
2021年08月12日Systemic lupus erythematosusSystemic lupus erythematosus (autoimmune disease) with inflammatory skin of the fingers.、クレジット：ＣＡＶＡＬＬＩＮＩ ＪＡＭＥＳ ／ ＢＳＩＰ／Ｕｎｉｖｅｒｓａｌ Ｉｍａｇｅｓ Ｇｒｏｕｐ／共同通信イメージズ
商品コード: 2022082511451
2021年11月21日Canada News - November 21, 2021November 21, 2021, Ottawa, ON, CAN: The name of Sen. Josee Forest-Niesing, who died after being hospitalized with COVID-19, is seen among the names of members of the Senate, in the Senate of Canada Building in Ottawa, on Sunday, Nov. 21, 2021. A statement from the office of Forest-Niesing said she was fully vaccinated against COVID-19 but was vulnerable due to an autoimmune condition. (Credit Image: © Justin Tang/The Canadian Press via ZUMA Press)、クレジット：©Ｊｕｓｔｉｎ Ｔａｎｇ／Ｔｈｅ Ｃａｎａｄｉａｎ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｃａｎａｄａ ａｎｄ Ｕ．Ｓ． ＲＩＧＨＴＳ ＯＵＴ
商品コード: 2021112204745
2021年11月21日Canada News - November 21, 2021November 21, 2021, Ottawa, ON, CAN: The name of Sen. Josee Forest-Niesing, who died after being hospitalized with COVID-19, is seen among the names of members of the Senate, in the Senate of Canada Building in Ottawa, on Sunday, Nov. 21, 2021. A statement from the office of Forest-Niesing said she was fully vaccinated against COVID-19 but was vulnerable due to an autoimmune condition. (Credit Image: © Justin Tang/The Canadian Press via ZUMA Press)、クレジット：©Ｊｕｓｔｉｎ Ｔａｎｇ／Ｔｈｅ Ｃａｎａｄｉａｎ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｃａｎａｄａ ａｎｄ Ｕ．Ｓ． ＲＩＧＨＴＳ ＯＵＴ
商品コード: 2021112204764
2022年09月21日Autoimmune DisorderSeptember 21, 2022, DUBUQUE, IOWA, USA: Carole Schmidt, left undergoes Intravenous immunoglobulin (IVIg) therapy for Immune thrombocytopenia (also known as ITP) at the MercyOne Cancer Center in Dubuque, Iowa. ITP is an autoimmune disorder causing internal bruising and an increased incidence of sometimes life-threatening internal bleeding. Bleeding occurs because the immune system attacks a certain type of cell - platelets - which are needed to help control bleeding. ITP is more common among young women and children. The risk appears to be higher in people who also have diseases such as rheumatoid arthritis, lupus and antiphospholipid syndrome. Research indicates ITP patients often have had a virus or viral infection about three weeks before developing ITP. Scientists believe that the body, when making antibodies against the virus, may have ‘‘accidentally‘‘ made an antibody that sticks to the platelet cells. The body then recognizes these platelet cells with antibodies as foreign cells and destroys them. Th...
商品コード: 2022092703185
2022年09月21日Autoimmune DisorderSeptember 21, 2022, DUBUQUE, IOWA, USA: Immune Globulin Intravenous is used in intravenous immunoglobulin therapy (IVIg) to raise blood platelet counts quickly. IVIg is an infusion given with a needle and requires sitting still for some time in an infusion center while the medicine goes into the veins. Most patients with Immune thrombocytopenia (ITP) start with a round of steroids to stop the body from destroying platelets and quickly raise platelet counts. Unfortunately, steroids can also have side effects, such as insomnia, weight gain, and mood changes. Thatââ¬â¢s 1 of the reasons why the American Society of Hematology (ASH) recommends the use of steroids for no more than 6 weeks. (Credit Image: © Kevin E. Schmidt/ZUMA Press Wire)、クレジット：©Ｋｅｖｉｎ Ｅ． Ｓｃｈｍｉｄｔ／ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2022092703152
2022年09月21日Autoimmune DisorderSeptember 21, 2022, DUBUQUE, IOWA, USA: Immune Globulin Intravenous is used in intravenous immunoglobulin therapy (IVIg) to raise blood platelet counts quickly. IVIg is an infusion given with a needle and requires sitting still for some time in an infusion center while the medicine goes into the veins. Most patients with Immune thrombocytopenia (ITP) start with a round of steroids to stop the body from destroying platelets and quickly raise platelet counts. Unfortunately, steroids can also have side effects, such as insomnia, weight gain, and mood changes. Thatââ¬â¢s 1 of the reasons why the American Society of Hematology (ASH) recommends the use of steroids for no more than 6 weeks. (Credit Image: © Kevin E. Schmidt/ZUMA Press Wire)、クレジット：©Ｋｅｖｉｎ Ｅ． Ｓｃｈｍｉｄｔ／ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2022092703165
2022年09月21日Autoimmune DisorderSeptember 21, 2022, DUBUQUE, IOWA, USA: Immune Globulin Intravenous is used in intravenous immunoglobulin therapy (IVIg) to raise blood platelet counts quickly. IVIg is an infusion given with a needle and requires sitting still for some time in an infusion center while the medicine goes into the veins. Most patients with Immune thrombocytopenia (ITP) start with a round of steroids to stop the body from destroying platelets and quickly raise platelet counts. Unfortunately, steroids can also have side effects, such as insomnia, weight gain, and mood changes. Thatââ¬â¢s 1 of the reasons why the American Society of Hematology (ASH) recommends the use of steroids for no more than 6 weeks. (Credit Image: © Kevin E. Schmidt/ZUMA Press Wire)、クレジット：©Ｋｅｖｉｎ Ｅ． Ｓｃｈｍｉｄｔ／ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2022092703213
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 A man is seen at Pharmasyntez Nord plant before the opening ceremony of the second stage of the plant, in St. Petersburg, Russia. The second stage of the Pharmasyntez-Nord plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104352
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 President of the Pharmasyntez group of companies Vikram Punia and St. Petersburg Governor Alexander Beglov attend the opening ceremony of the second stage of the plant, in St. Petersburg, Russia. The second stage of the Pharmasyntez-Nord plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104701
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 Director General of the Pharmasyntez Nord company Mikhail Kvasnikov, President of the Pharmasyntez group of companies Vikram Punia and St. Petersburg Governor Alexander Beglov attend the opening ceremony of the second stage of the plant, in St. Petersburg, Russia. The second stage of the Pharmasyntez-Nord plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104703
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 President of the Pharmasyntez group of companies Vikram Punia and St. Petersburg Governor Alexander Beglov shake hands during the opening ceremony of the second stage of the plant, in St. Petersburg, Russia. The second stage of the Pharmasyntez-Nord plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104702
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 President of the Pharmasyntez group of companies Vikram Punia and St. Petersburg Governor Alexander Beglov attend the opening ceremony of the second stage of the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104927
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 Director General of the Pharmasyntez-Nord Mikahil Kvasnikov and St. Petersburg Governor Alexander Beglov attend he opening ceremony of the second stage of the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104925
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 Director General of the Pharmasyntez-Nord Mikahil Kvasnikov and St. Petersburg Governor Alexander Beglov shake hands during the opening ceremony of the second stage of the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104926
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105852
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105857
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105849
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 St. Petersburg Governor Alexander Beglov, accompanied by Director General of the Pharmasyntez Nord company Mikhail Kvasnikov and President of the Pharmasyntez group of companies Vikram Punia, visits the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Anton Vergun / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104931
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 St. Petersburg Governor Alexander Beglov visits the Pharmasyntez-Nord plant in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104929
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105839
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 St. Petersburg Governor Alexander Beglov visits the Pharmasyntez-Nord plant in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Anton Vergun / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104932
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105666
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105835
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105848
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105851
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105836
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105847
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105845
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105838
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105850
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105846
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105841
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105840
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105837
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105844
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105843
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105842
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 St. Petersburg Governor Alexander Beglov attends the opening ceremony of the second stage of the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105879
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 St. Petersburg Governor Alexander Beglov, accompanied by Director General of the Pharmasyntez Nord company Mikhail Kvasnikov attends the opening ceremony Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105877
2023年03月30日Russia Pharmaceutical Industry Pharmasyntez Nord30.03.2023 A view shows the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine. Alexei Danichev / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040105880
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: Singer Ana Guerra during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053103995
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Madrid, Spain: Merck CEO Manuel Zafra during the celebration of World Multiple Sclerosis Day at the Teatro Nuevo Albéniz in Madrid on May 30, 2023, in Madrid, Spain. The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※France, Germany, Spain and UK Rights OUT
商品コード: 2023053105407
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: Influencer Alberto ÃÂvila during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053105469
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: Influencer Néstor Seller during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053103944
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Madrid, Spain: Influencer Néstor Seller during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※France, Germany, Spain and UK Rights OUT
商品コード: 2023053103945
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: Singer Agoney during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053103962
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: Singer Abraham Mateo during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053103935
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Madrid, Spain: Influencer Alberto Ãvila during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※France, Germany, Spain and UK Rights OUT
商品コード: 2023053105428
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: Singer Samantha Gilabert during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053105429
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: Merck CEO Manuel Zafra during the celebration of World Multiple Sclerosis Day at the Teatro Nuevo Albéniz in Madrid on May 30, 2023, in Madrid, Spain. The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053105412
2023年05月30日World Multiple Sclerosis Day MadridMay 30, 2023, Madrid, Spain: Singer ANA GUERRA during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albuniz in Madrid. The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain. (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053103938
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: Cadena Dial presenters Jaime Moreno and Saray Esteso during the celebration of World Multiple Sclerosis Day at the Teatro Nuevo Albéniz in Madrid on May 30, 2023, in Madrid, Spain. The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053105444
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Madrid, Spain: Basketball player, Asier de la Iglesia, during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※France, Germany, Spain and UK Rights OUT
商品コード: 2023053105400
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: Singer Samantha Gilabert during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053105416
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Madrid, Spain: Influencer LucÃa MartÃnez during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※France, Germany, Spain and UK Rights OUT
商品コード: 2023053105405
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: Basketball player, Asier de la Iglesia, during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053105406
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Madrid, Spain: Merck CEO Manuel Zafra during the celebration of World Multiple Sclerosis Day at the Teatro Nuevo Albéniz in Madrid on May 30, 2023, in Madrid, Spain. The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※France, Germany, Spain and UK Rights OUT
商品コード: 2023053105408
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: Influencer Alberto ÃÂvila during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053105386
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Madrid, Spain: The musician Polo Nandez during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※France, Germany, Spain and UK Rights OUT
商品コード: 2023053105204
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Madrid, Spain: Singer Antonio José during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※France, Germany, Spain and UK Rights OUT
商品コード: 2023053105176
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: The musician Polo Nandez during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053105135
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: Singer Carlos Baute during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053103954
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Madrid, Spain: Singer Carlos Baute during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※France, Germany, Spain and UK Rights OUT
商品コード: 2023053103956
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Madrid, Spain: Singer Abraham Mateo during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※France, Germany, Spain and UK Rights OUT
商品コード: 2023053103930
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Madrid, Spain: Singer Carlos Baute during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※France, Germany, Spain and UK Rights OUT
商品コード: 2023053103929
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: Influencer LucÃÂa MartÃÂnez during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053105446
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Madrid, Spain: Influencer Néstor Seller during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※France, Germany, Spain and UK Rights OUT
商品コード: 2023053103943
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: Singer Carlos Baute during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053103933
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Madrid, Spain: Singer Ana Guerra during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※France, Germany, Spain and UK Rights OUT
商品コード: 2023053103939
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: Singer Abraham Mateo during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053103947
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: Influencer LucÃÂa MartÃÂnez during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053105430
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: Singer Samantha Gilabert during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053105431
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Madrid, Spain: Singer Samantha Gilabert during the celebration of World Multiple Sclerosis Day, at the Teatro Nuevo Albéniz in Madrid, on May 30, 2023, in Madrid (Spain). The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※France, Germany, Spain and UK Rights OUT
商品コード: 2023053105409
2023年05月30日Cadena Dial and Merck celebrate the World Multiple Sclerosis DayMay 30, 2023, Madrid, Spain: Merck CEO Manuel Zafra during the celebration of World Multiple Sclerosis Day at the Teatro Nuevo Albéniz in Madrid on May 30, 2023, in Madrid, Spain. The event has been organized by the science and technology company Merck and Cadena Dial. Multiple sclerosis or MS is a chronic, autoimmune, neurological disease that affects 55,000 people in Spain and is the second leading cause of disability in young adults, second only to traffic accidents. It is generally diagnosed between the ages of 20 and 40 and affects women three times more often than men...30 MAY 2023;EVENT;MERCK;SCIENCE;TECHNOLOGY;MULTIPLE SCLEROSIS;SCLEROSIS;NEUROLOGY;AUTOIMMUNE;CHRONIC..Alberto Ortega / Europa Press..05/30/2023 (Credit Image: © Alberto Ortega/Contacto via ZUMA Press)、クレジット：©Ａｌｂｅｒｔｏ Ｏｒｔｅｇａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Spain Rights OUT
商品コード: 2023053105422
- 1
- 2
